THC is perhaps the most well-known cannabinoid within cannabis. THC, short for tetrahydrocannabinol, is famously responsible for cannabis's psychoactive effects. Because of this, many cannabis users assume that a strain with a higher THC percentage will always be more heavy-hitting and have stronger psychoactive effects. Recent reports are showing that consumers are demanding higher and higher THC levels/percentages.
A recent report on recent trends by an industry insider, said: "What we've been seeing over the last few years, is an increasing demand for high THC strains. While we're learning more about how the present terpenes in a strain might play a more important role in the effect or 'high', consumers actually consider their options in a simple way: "get the highest THC for lowest $. Cultivators have to play the game and stay on top of the preferred strains in the market.
Or better yet, one step ahead. Tastes and preferences change very frequently in this market, partly fueled by breeders' constant production of new cannabis strains. Growers who have access to a breeder or employee who can start a program would be wise to develop and name their own strains. When you're the only producer of a certain strain, your competitive edge improves."
Active Cannabis companies in the markets this week include Ikänik Farms Inc., Organigram Holdings Inc., Green Thumb Industries Inc., Trulieve Cannabis Corp., MedMen Enterprises Inc.
The cannabis industry has been fighting for legalization for decades. With each passing year, the cannabis industry matures and continues to grow exponentially. The market value of the cannabis industry is projected by all industry reports to continue strong growth for several years to come. These projections come at a time when cannabis remains federally illegal. As legalization grows, so will the size of the market, but also in the methods of production and cannabis consumer behavior. Approximately 36 states and 4 territories (District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands) have enacted measures in the medical marijuana industry and recreational can't be far behind… consumer demand is playing its part in shaping the successful product lines and brands.
Ikänik Farms, Inc. is also pleased to announce that its wholly-owned, Colombian subsidiary Pideka SAS has completed the registration and commercialization process of six cannabis-based cosmetic products through the National Institute of Drug and Food Surveillance, the governing body in Colombia responsible for new product registrations.
"We are excited to open the door to multiple countries concurrent with our product registrations and look forward to better serving the Latin American markets in the near future," said Brian Baca, CEO of Ikänik Farms.
The product suite is comprised of cosmetic products and offers skincare benefits, using the unique beneficial properties of cannabis-derived oil. All products are designed with plant-derived oils and cultivated under strict quality and control standards, fortified with organic and natural ingredients to maximize the effect of the specific product and its purpose.
The products are medically authorized in three additional Latin American countries through the Colombian registration, opening the door for future product recognition and registration in the participating member countries of the Andean Pact, which includes Bolivia, Colombia, Ecuador and Peru. The Andean Pact accelerates the Company's ability to open multiple markets through a singular, unified registration.
"We are proud to have completed this major milestone and have positioned ourselves to be a leader and cornerstone of product quality within the global marketplace, with an initial emphasis in Latin America and Europe." said Borja Sanz de Madrid, President of Ikänik Farms International, Inc.
For more information:
Ikänik Farms International, Inc.